John Stansel
Stock Analyst at JP Morgan
(2.21)
# 3,697
Out of 5,182 analysts
14
Total ratings
71.43%
Success rate
3.43%
Average return
Main Sectors:
Stocks Rated by John Stansel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Neutral | $45 → $41 | $37.30 | +9.92% | 5 | Mar 19, 2026 | |
| HSIC Henry Schein | Maintains: Overweight | $78 → $92 | $75.34 | +22.11% | 2 | Feb 25, 2026 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $23 → $26 | $20.50 | +26.83% | 2 | Feb 5, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $272 → $184 | $145.88 | +26.13% | 2 | Jul 29, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $148 → $149 | $191.51 | -22.20% | 1 | Nov 17, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $259 → $261 | $260.93 | +0.03% | 1 | Nov 17, 2023 | |
| ONON On Holding AG | Initiates: Buy | $31 | $33.55 | -7.60% | 1 | Apr 19, 2022 |
Centene
Mar 19, 2026
Maintains: Neutral
Price Target: $45 → $41
Current: $37.30
Upside: +9.92%
Henry Schein
Feb 25, 2026
Maintains: Overweight
Price Target: $78 → $92
Current: $75.34
Upside: +22.11%
Alignment Healthcare
Feb 5, 2026
Maintains: Overweight
Price Target: $23 → $26
Current: $20.50
Upside: +26.83%
Molina Healthcare
Jul 29, 2025
Maintains: Neutral
Price Target: $272 → $184
Current: $145.88
Upside: +26.13%
Quest Diagnostics
Nov 17, 2023
Maintains: Neutral
Price Target: $148 → $149
Current: $191.51
Upside: -22.20%
Labcorp Holdings
Nov 17, 2023
Maintains: Overweight
Price Target: $259 → $261
Current: $260.93
Upside: +0.03%
On Holding AG
Apr 19, 2022
Initiates: Buy
Price Target: $31
Current: $33.55
Upside: -7.60%